APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Allergy Treatments and Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Allergy Treatments and Drugs Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchDrug Allergy Treatments and Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Allergy Treatments and Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drug Allergy Treatments and Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Allergy Treatments and Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Allergy Treatments and Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Allergy Treatments and Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Allergy Treatments and Drugs include AAFA, Allergan plc, Allergy Therapeutics, Circassia, HAL Allergy Group, Mayo Clinic, Stallergenes Greer, Sunovion Pharmaceuticals and GlaxoSmithKline plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Allergy Treatments and Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Allergy Treatments and Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Allergy Treatments and Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Allergy Treatments and Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drug Allergy Treatments and Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Allergy Treatments and Drugs Market by Company

AAFA

Allergan plc

Allergy Therapeutics

Circassia

HAL Allergy Group

Mayo Clinic

Stallergenes Greer

Sunovion Pharmaceuticals

GlaxoSmithKline plc

Teva Pharmaceutical Industries

Drug Allergy Treatments and Drugs Segment by Type

Insulin

Penicillin and Related Drugs

Sulfa Drugs

Chemotherapy Drugs

Iodine

Other

Drug Allergy Treatments and Drugs Segment by Application

Pharmaceutical & Biotechnology Companies

Diagnostic Laboratories

Hospitals

Research & Academic Laboratories

Drug Allergy Treatments and Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Allergy Treatments and Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Allergy Treatments and Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Allergy Treatments and Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Allergy Treatments and Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drug Allergy Treatments and Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Table 2. Major Company of Penicillin and Related Drugs Table 3. Major Company of Sulfa Drugs Table 4. Major Company of Chemotherapy Drugs Table 5. Major Company of Iodine Table 6. Major Company of Other Table 7. Global Drug Allergy Treatments and Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 9. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Drug Allergy Treatments and Drugs Price by Type (2021-2026) & (US$/Unit) Table 13. Global Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 14. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Drug Allergy Treatments and Drugs Price by Type (2027-2032) & (US$/Unit) Table 18. North America Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 19. North America Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 21. Europe Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 25. Latin America Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Drug Allergy Treatments and Drugs Industry Trends Table 29. Drug Allergy Treatments and Drugs Industry Drivers Table 30. Drug Allergy Treatments and Drugs Industry Opportunities and Challenges Table 31. Drug Allergy Treatments and Drugs Industry Restraints Table 32. Global Drug Allergy Treatments and Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Drug Allergy Treatments and Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Drug Allergy Treatments and Drugs Sales by Company (2021-2026) & (K Units) Table 35. Global Drug Allergy Treatments and Drugs Sales Share by Company (2021-2026) Table 36. Global Drug Allergy Treatments and Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Drug Allergy Treatments and Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Drug Allergy Treatments and Drugs Major Company Production Sites and Headquarters Table 39. Global Drug Allergy Treatments and Drugs Company, Product Type & Application Table 40. Global Drug Allergy Treatments and Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Drug Allergy Treatments and Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Drug Allergy Treatments and Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Drug Allergy Treatments and Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Drug Allergy Treatments and Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Drug Allergy Treatments and Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Drug Allergy Treatments and Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Drug Allergy Treatments and Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Drug Allergy Treatments and Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 61. Global Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Drug Allergy Treatments and Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Drug Allergy Treatments and Drugs Price by Application (2027-2032) & (US$/Unit) Table 65. North America Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 66. North America Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 68. Europe Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 72. Latin America Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. AAFA Company Information Table 76. AAFA Business Overview Table 77. AAFA Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. AAFA Drug Allergy Treatments and Drugs Product Portfolio Table 79. AAFA Recent Development Table 80. Allergan plc Company Information Table 81. Allergan plc Business Overview Table 82. Allergan plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Allergan plc Drug Allergy Treatments and Drugs Product Portfolio Table 84. Allergan plc Recent Development Table 85. Allergy Therapeutics Company Information Table 86. Allergy Therapeutics Business Overview Table 87. Allergy Therapeutics Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio Table 89. Allergy Therapeutics Recent Development Table 90. Circassia Company Information Table 91. Circassia Business Overview Table 92. Circassia Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Circassia Drug Allergy Treatments and Drugs Product Portfolio Table 94. Circassia Recent Development Table 95. HAL Allergy Group Company Information Table 96. HAL Allergy Group Business Overview Table 97. HAL Allergy Group Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio Table 99. HAL Allergy Group Recent Development Table 100. Mayo Clinic Company Information Table 101. Mayo Clinic Business Overview Table 102. Mayo Clinic Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio Table 104. Mayo Clinic Recent Development Table 105. Stallergenes Greer Company Information Table 106. Stallergenes Greer Business Overview Table 107. Stallergenes Greer Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio Table 109. Stallergenes Greer Recent Development Table 110. Sunovion Pharmaceuticals Company Information Table 111. Sunovion Pharmaceuticals Business Overview Table 112. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio Table 114. Sunovion Pharmaceuticals Recent Development Table 115. GlaxoSmithKline plc Company Information Table 116. GlaxoSmithKline plc Business Overview Table 117. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio Table 119. GlaxoSmithKline plc Recent Development Table 120. Teva Pharmaceutical Industries Company Information Table 121. Teva Pharmaceutical Industries Business Overview Table 122. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio Table 124. Teva Pharmaceutical Industries Recent Development Table 125. North America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. North America Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 127. North America Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2026) Table 128. North America Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 129. North America Drug Allergy Treatments and Drugs Sales Market Share Forecast by Country (2027-2032) Table 130. North America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Drug Allergy Treatments and Drugs Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Drug Allergy Treatments and Drugs Market Share by Country (2021-2026) Table 133. North America Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Drug Allergy Treatments and Drugs Market Share Forecast by Country (2027-2032) Table 135. Europe Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 137. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2026) Table 138. Europe Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 139. Europe Drug Allergy Treatments and Drugs Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Drug Allergy Treatments and Drugs Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Drug Allergy Treatments and Drugs Market Share by Country (2021-2026) Table 143. Europe Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Drug Allergy Treatments and Drugs Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 147. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 149. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Drug Allergy Treatments and Drugs Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Drug Allergy Treatments and Drugs Market Share by Country (2021-2026) Table 153. Asia-Pacific Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Drug Allergy Treatments and Drugs Market Share Forecast by Country (2027-2032) Table 155. Latin America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Latin America Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 157. Latin America Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2026) Table 158. Latin America Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 159. Latin America Drug Allergy Treatments and Drugs Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Drug Allergy Treatments and Drugs Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Drug Allergy Treatments and Drugs Market Share by Country (2021-2026) Table 163. Latin America Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Drug Allergy Treatments and Drugs Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 167. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 169. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Drug Allergy Treatments and Drugs Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Drug Allergy Treatments and Drugs Market Share by Country (2021-2026) Table 173. Middle East and Africa Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Drug Allergy Treatments and Drugs Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Drug Allergy Treatments and Drugs Distributors List Table 178. Drug Allergy Treatments and Drugs Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Drug Allergy Treatments and Drugs Image Figure 2. Global Drug Allergy Treatments and Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Allergy Treatments and Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Allergy Treatments and Drugs Sales (2021-2032) & (K Units) Figure 5. Insulin Image Figure 6. Global Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Penicillin and Related Drugs Image Figure 8. Global Penicillin and Related Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Sulfa Drugs Image Figure 10. Global Sulfa Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 11. Chemotherapy Drugs Image Figure 12. Global Chemotherapy Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 13. Iodine Image Figure 14. Global Iodine Sales YoY Growth (2021-2032) & (K Units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Drug Allergy Treatments and Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Drug Allergy Treatments and Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Drug Allergy Treatments and Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Drug Allergy Treatments and Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Drug Allergy Treatments and Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Drug Allergy Treatments and Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Pharmaceutical & Biotechnology Companies Image Figure 32. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Diagnostic Laboratories Image Figure 34. Global Diagnostic Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 35. Hospitals Image Figure 36. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 37. Research & Academic Laboratories Image Figure 38. Global Research & Academic Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Drug Allergy Treatments and Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Drug Allergy Treatments and Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Drug Allergy Treatments and Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Drug Allergy Treatments and Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Drug Allergy Treatments and Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Drug Allergy Treatments and Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Drug Allergy Treatments and Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Drug Allergy Treatments and Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Drug Allergy Treatments and Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Drug Allergy Treatments and Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Drug Allergy Treatments and Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Drug Allergy Treatments and Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Drug Allergy Treatments and Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Drug Allergy Treatments and Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Drug Allergy Treatments and Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Drug Allergy Treatments and Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Drug Allergy Treatments and Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Drug Allergy Treatments and Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Drug Allergy Treatments and Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Drug Allergy Treatments and Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Drug Allergy Treatments and Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Drug Allergy Treatments and Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Penicillin and Related Drugs
  • Sulfa Drugs
  • Chemotherapy Drugs
  • Iodine
  • Other
Applications
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
  • Research & Academic Laboratories
Companies covered
  • AAFA
  • Allergan plc
  • Allergy Therapeutics
  • Circassia
  • HAL Allergy Group
  • Mayo Clinic
  • Stallergenes Greer
  • Sunovion Pharmaceuticals
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drug Allergy Treatments and Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drug Allergy Treatments and Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drug Allergy Treatments and Drugs Market by Type
  6. 1.3.1 Insulin
  7. 1.3.2 Penicillin and Related Drugs
  8. 1.3.3 Sulfa Drugs
  9. 1.3.4 Chemotherapy Drugs
  10. 1.3.5 Iodine
  11. 1.3.6 Other
  12. 1.4 Global Drug Allergy Treatments and Drugs Market Size by Type
  13. 1.4.1 Global Drug Allergy Treatments and Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Drug Allergy Treatments and Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Drug Allergy Treatments and Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Drug Allergy Treatments and Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Drug Allergy Treatments and Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Drug Allergy Treatments and Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Drug Allergy Treatments and Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Drug Allergy Treatments and Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drug Allergy Treatments and Drugs Industry Trends
  2. 2.2 Drug Allergy Treatments and Drugs Industry Drivers
  3. 2.3 Drug Allergy Treatments and Drugs Industry Opportunities and Challenges
  4. 2.4 Drug Allergy Treatments and Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drug Allergy Treatments and Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Drug Allergy Treatments and Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Drug Allergy Treatments and Drugs Price (2021-2026)
  4. 3.4 Global Drug Allergy Treatments and Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Allergy Treatments and Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Drug Allergy Treatments and Drugs Company, Product Type & Application
  7. 3.7 Global Drug Allergy Treatments and Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Allergy Treatments and Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Allergy Treatments and Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Allergy Treatments and Drugs Tier 1, Tier 2, and Tier 3
4 Drug Allergy Treatments and Drugs Regional Status and Outlook
  1. 4.1 Global Drug Allergy Treatments and Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drug Allergy Treatments and Drugs Historic Market Size by Region
  3. 4.2.1 Global Drug Allergy Treatments and Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drug Allergy Treatments and Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drug Allergy Treatments and Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drug Allergy Treatments and Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Drug Allergy Treatments and Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drug Allergy Treatments and Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drug Allergy Treatments and Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drug Allergy Treatments and Drugs by Application
  1. 5.1 Drug Allergy Treatments and Drugs Market by Application
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Diagnostic Laboratories
  4. 5.1.3 Hospitals
  5. 5.1.4 Research & Academic Laboratories
  6. 5.2 Global Drug Allergy Treatments and Drugs Market Size by Application
  7. 5.2.1 Global Drug Allergy Treatments and Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Drug Allergy Treatments and Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Drug Allergy Treatments and Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Drug Allergy Treatments and Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Drug Allergy Treatments and Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Drug Allergy Treatments and Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Drug Allergy Treatments and Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Drug Allergy Treatments and Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AAFA
  2. 6.1.1 AAFA Company Information
  3. 6.1.2 AAFA Business Overview
  4. 6.1.3 AAFA Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AAFA Drug Allergy Treatments and Drugs Product Portfolio
  6. 6.1.5 AAFA Recent Developments
  7. 6.2 Allergan plc
  8. 6.2.1 Allergan plc Company Information
  9. 6.2.2 Allergan plc Business Overview
  10. 6.2.3 Allergan plc Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan plc Drug Allergy Treatments and Drugs Product Portfolio
  12. 6.2.5 Allergan plc Recent Developments
  13. 6.3 Allergy Therapeutics
  14. 6.3.1 Allergy Therapeutics Company Information
  15. 6.3.2 Allergy Therapeutics Business Overview
  16. 6.3.3 Allergy Therapeutics Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio
  18. 6.3.5 Allergy Therapeutics Recent Developments
  19. 6.4 Circassia
  20. 6.4.1 Circassia Company Information
  21. 6.4.2 Circassia Business Overview
  22. 6.4.3 Circassia Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Circassia Drug Allergy Treatments and Drugs Product Portfolio
  24. 6.4.5 Circassia Recent Developments
  25. 6.5 HAL Allergy Group
  26. 6.5.1 HAL Allergy Group Company Information
  27. 6.5.2 HAL Allergy Group Business Overview
  28. 6.5.3 HAL Allergy Group Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio
  30. 6.5.5 HAL Allergy Group Recent Developments
  31. 6.6 Mayo Clinic
  32. 6.6.1 Mayo Clinic Company Information
  33. 6.6.2 Mayo Clinic Business Overview
  34. 6.6.3 Mayo Clinic Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio
  36. 6.6.5 Mayo Clinic Recent Developments
  37. 6.7 Stallergenes Greer
  38. 6.7.1 Stallergenes Greer Company Information
  39. 6.7.2 Stallergenes Greer Business Overview
  40. 6.7.3 Stallergenes Greer Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio
  42. 6.7.5 Stallergenes Greer Recent Developments
  43. 6.8 Sunovion Pharmaceuticals
  44. 6.8.1 Sunovion Pharmaceuticals Company Information
  45. 6.8.2 Sunovion Pharmaceuticals Business Overview
  46. 6.8.3 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio
  48. 6.8.5 Sunovion Pharmaceuticals Recent Developments
  49. 6.9 GlaxoSmithKline plc
  50. 6.9.1 GlaxoSmithKline plc Company Information
  51. 6.9.2 GlaxoSmithKline plc Business Overview
  52. 6.9.3 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio
  54. 6.9.5 GlaxoSmithKline plc Recent Developments
  55. 6.10 Teva Pharmaceutical Industries
  56. 6.10.1 Teva Pharmaceutical Industries Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Drug Allergy Treatments and Drugs Sales by Country
  2. 7.1.1 North America Drug Allergy Treatments and Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drug Allergy Treatments and Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drug Allergy Treatments and Drugs Market Size by Country
  6. 7.2.1 North America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drug Allergy Treatments and Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drug Allergy Treatments and Drugs Sales by Country
  2. 8.1.1 Europe Drug Allergy Treatments and Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drug Allergy Treatments and Drugs Market Size by Country
  6. 8.2.1 Europe Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drug Allergy Treatments and Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drug Allergy Treatments and Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Drug Allergy Treatments and Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drug Allergy Treatments and Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drug Allergy Treatments and Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drug Allergy Treatments and Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drug Allergy Treatments and Drugs Sales by Country
  2. 10.1.1 South America Drug Allergy Treatments and Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drug Allergy Treatments and Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drug Allergy Treatments and Drugs Market Size by Country
  6. 10.2.1 South America Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drug Allergy Treatments and Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Drug Allergy Treatments and Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drug Allergy Treatments and Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drug Allergy Treatments and Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Drug Allergy Treatments and Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drug Allergy Treatments and Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drug Allergy Treatments and Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drug Allergy Treatments and Drugs Value Chain Analysis
  2. 12.1.1 Drug Allergy Treatments and Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drug Allergy Treatments and Drugs Production Mode & Process
  7. 12.2 Drug Allergy Treatments and Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drug Allergy Treatments and Drugs Distributors
  10. 12.2.3 Drug Allergy Treatments and Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst